TEIJIN PHARMA LIMITED

It is a link to move in the page.

  • To global navigation
  • To the text
  • To local navigation
  • To site information

Human Chemistry, Human Solutions TEIJIN

Font Size
  • Font size change to 'Small size'
  • The font size is 'Medium size'
  • Font size change to 'Large size'

SEARCH IN THIS SITE

Language
Japanese

news release

April 1, 2010
Teijin Pharma and Astellas Pharma Enter into Agreement for Marketing Rights of TMX-67 in China and Hong Kong  — Novel Drug for Chronic Management of Hyperuricemia in Gout Patients —
March 11, 2010
Teijin Pharma Strengthens Presence in Spain’s Home Healthcare Field Furthers Business Expansion in European Market

Archives

corporate profile

  • Message from the President
  • Corporate Profile
  • Overview of Core Business
  • Global Operations
  • Compliance
  • Organization
  • Corporate Social Responsibility(CSR)
  • Synergies of the Teijin Group
  • Research and Development
  • Customer and marketing support services
  • History
  • Office Locations

site information

  • Site Map
  • Contact Us
  • Global Alliances (Contact Us)
  • Terms of Use
  • Privacy Policy

Copyright TEIJIN PHARMA LIMITED. All Rights Reserve